Hossein Jadvar, MD, PhD, MPH, MBA, MSL

Hossein Jadvar, MD, PhD, MPH, MBA, MSL, FACNM, FSNMMI
Professor of Radiology, Radiation Oncology, Urology, and Biomedical Engineering (Tenured)
Keck School of Medicine and Viterbi School of Engineering
University of Southern California, Los Angeles, CA, USA
Vice Chair, USC Radiation Safety Committee
Senator, USC Keck School of Medicine Faculty Council
Co-Leader, Genitourinary Disease Affinity Group (GU-DAG), USC Norris CCC
Past President & Fellow, American College of Nuclear Medicine
Past President & Fellow, Society of Nuclear Medicine and Molecular Imaging
Associate/Deputy Editor, JNM, EJNMMI, CNM, Radiology, Theranostics
Chair, U.S. Nuclear Regulatory Commission Advisory Committee on Medical Uses of Isotopes
Director, American Board of Nuclear Medicine
Distinguished Investigator, Academy for Radiology and Biomedical Imaging Research

Dr. Jadvar is a tenured Professor of Radiology in the Keck School of Medicine (KSOM), at the University of Southern California (USC), Los Angeles, California, USA. He has joint appointments as Professor of Radiation Oncology and Professor of Urology, KSOM, and Professor of Biomedical Engineering, USC Viterbi School of Engineering, and is a full member of the USC Norris Comprehensive Cancer Center. He is the past president and fellow of both the American College of Nuclear Medicine (ACNM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI). He is also past president of the SNMMI PET Center of Excellence and the SNMMI Therapy Center of Excellence.

Dr. Jadvar immigrated to the United States in 1978 at age of 17 years, after completing his secondary education at the elite Alborz High School (circa. 1873) in Tehran, Iran, and became a naturalized U.S. citizen in 1995. He received the BS degree in chemical engineering from Iowa State University, Ames (1982), MS in biomedical engineering from University of Wisconsin, Madison (1984), MS in computer engineering (1986) and PhD in bioengineering (1988), both from the University of Michigan, Ann Arbor, the MD degree from the University of Chicago Pritzker School of Medicine (1993), Master’s in Public Health (MPH) degree from Harvard University (2005), the Executive Master’s in Business Administration (MBA) from the USC Marshall School of Business (2007), and Master’s in Studies of Law (MSL) from the USC Gould School of Law (2024). He was an intern in internal medicine at the University of California San Francisco (UCSF) during 1993-94, a diagnostic radiology and nuclear medicine resident at Stanford University, during 1994-98, and a clinical fellow in nuclear oncology and positron emission tomography (PET) with the Harvard Medical School Joint Program in Nuclear Medicine, during 1998-99. He has completed executive educational certificate programs in clinical effectiveness at Harvard Medical School, and in leadership at the Wharton School of Business of the University of Pennsylvania. He has also attended summer educational enrichment programs at the University of Oxford, UK, and the University of Cambridge, UK.

He was a Visiting Scientist in Bioengineering at the California Institute of Technology (Caltech) in Pasadena, during 2001-2006. Dr. Jadvar is on the leadership editorial boards of Journal of Nuclear Medicine (Associate Editor), European Journal of Nuclear Medicine and Molecular Imaging (Associate Editor), Radiology (Consultant to the Editor), Theranostics (Associate Editor), and Clinical Nuclear Medicine (Deputy Editor), and is member of the editorial boards of many other peer-reviewed scientific and medical journals. He was inducted into the Tau Beta PI, Eta Kappa Nu, and Sigma Xi honor societies, and is the past recipient of the NIH Resident Research Award (1994), the RSNA Roentgen Resident Research Award (1997), the SNMMI Mark Tetalman Young Investigator Award (2000), the Western Regional SNMMI Distinguished “Sanjiv Sam Gambhir” Scientist Award (2010) and Distinguished Service Award (2020), the Academy for Radiology and Biomedical Imaging Research Distinguished Investigator Award (2014), the inaugural fellowship in the USC Center for Excellence in Research, the inaugural Prof. Ajit Padhy Oration Award from the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH), the Prof. RD Lee Oration Award from the Association of Nuclear Physicians of India (2023), the SNMMI PET Center of Excellence Peter E. Valk MD Memorial Award (2019), the Best Mentor Awards from both USC (2017) and ACNM (2018), the Outstanding Teacher of the Year Award (2023, 2024) from the USC Department of Radiology, the Lifetime Achievement Award from the ACNM (2023), and the Hampton Symposium Distinguished Alumnus Award from the Massachusetts General Hospital Department of Radiology, Harvard Medical School (2024). He has been named among the Best Doctors in America, the America’s Top Radiologists, and the Top Doctor in Los Angeles and Pasadena, California. He was an invited speaker and panelist in the Cancer Engineering Workshop of the U.S. National Academies of Sciences, Engineering, and Medicine (NASEM) in Washington, DC, in 2025.

Dr. Jadvar has been serving since 2019 as the nuclear medicine physician representative on the U.S. Nuclear Regulatory Commission (NRC) Advisory Committee on Medical Uses of Isotopes (ACMUI) and was appointed as the Vice Chair of this Committee in 2022, and as Chair in 2024. He was selected to serve on the Board of Directors of the American Board of Nuclear Medicine (ABNM) in 2023.

He has been a National Institutes of Health (NIH) funded investigator and serves on multiple NIH review panels (with one term as a chartered member for MEDI study section), and the Department of Defense (DOD) Congressionally Directed Medical Research Programs-Prostate Cancer Research Program, the Department of Energy (DOE) Isotope R&D and Production Program, and the Imaging Technology and Informatics Review Panel of the Cancer Prevention Research Institute of Texas (CPRIT). He holds 9 U.S. and European patents (esophageal electrocardiography and cardiac pacing instrumentation), has written 280 peer-reviewed journal articles, published 4 books, 41 book chapters, numerous conference abstracts and full articles, and has had more than 350 invited lectures and visiting professorships at numerous national and international venues. His research interests include translational molecular imaging research with particular current interest in prostate cancer, theranostics, and radiopharmaceutical therapy.

BOOKS
1. Jadvar H, Parker JA. Clinical PET and PET/CT. Springer-Verlag, Inc., London, UK. 2005. (ISBN 1 85233-838-5)
2. Jadvar H, Jacene H, Graham M (Eds.). Molecular Imaging: An Introduction. Cambridge University Press, Cambridge, UK. 2017. (ISBN 978-1-107-62128-2)
3. Jadvar H, Colletti PM (Eds.). Nuclear Medicine: The Essentials. Wolter-Kluwer, Inc., Philadelphia, PA. 2022. (ISBN-13: 978-1-4963-00645)
4. Gholamrezanejad A, Assadi M, Jadvar H (Eds.). Radiology-Nuclear Medicine Diagnostic Imaging: A Correlative Approach. John Wiley & Sons Ltd., Hoboken, NJ. 2023. (ISBN 9781119603610)

PATENTS
1. Jadvar H, Arzbaecher RC Artifact Suppressing Apparatus and Method. International Patent #WO/1989/009514, May 10, 1989
2. Metzger WT, Jadvar H. Variable Stiffness Esophageal Catheter. U.S. Patent #4,930,521, June 5, 1990.
3. Jadvar H, Metzger WT. Multiple Electrode Affixable Sheet. European Patent #EP381816A2, August 16, 1990
4. Jadvar H, Metzger WT. Multiple Electrode Affixable Sheet. European Patent #EP381816A2, November 7, 1990
5. Jadvar H, Arzbaecher RC. Method and Apparatus for Detection of Posterior Ischemia. U.S. Patent #5,010,888, April 30, 1991.
6. Jadvar H, Metzger WT. Multiple Electrode Affixable Sheet. U.S. Patent #5,069,215, December 3, 1991.
7. Metzger WT, Jadvar H. Variable Stiffness Esophageal Catheter. European Patent #90905336.5, January 21, 1992.
8. Jadvar H, Metzger WT. Multiple Electrode Affixable Sheet. U.S. Patent #5,109,851, May 5, 1992.
9. Metzger WT, Jadvar H. Expandable Esophageal Catheter. U.S. Patent #5,117,828, June 2, 1992.

PERSONAL INTERESTS
World Travel, Photography, Cosmology, Philosophy, Classical and Jazz music

Last update: 8/5/2026

• Office of Education, National Institutes of Health (NIH): NIH Resident Research Award, 1994
• Radiological Society of North America: Roentgen Resident/Fellow Research Award, 1997
• American College of Nuclear Physicians (ACNP): Resident Research Award, 1998
• Society of Nuclear Medicine: Marc Tetalman Young Investigator Award, 2000
• American College of Nuclear Medicine (ACNM): Fellow, 2003
• IEEE-Engineering in Medicine and Biology Society: Senior Member, 2006
• USC Center for Excellence in Research: Inaugural Faculty Fellow, 2007
   – 2010
• Medical Imaging (MEDI) Review Panel, U.S. National Institutes of Health (NIH): Charter Member, Medical Imaging Study Section, 2007
   – 2011
• PET Clinics and Theranostics (Prostate Cancer): Invited Guest Editor, 2009
• Western Regional Society of Nuclear Medicine: Distinguished Scientist Award, 2010
• Pasadena Magazine: San Gabriel Valley Top Doctors, 2010
   – 2024
• Best Doctors in America, 2013
   – 2024
• Academy for Radiology and Biomedical Imaging Research: Distinguished Investigator Award, 2014
• Journal of Nuclear Medicine (Supplement on Prostate Cancer): Invited Guest Editor, 2016
• Society of Nuclear Medicine and Molecular Imaging (SNMMI): Fellow, 2016
• World Association of Radiopharmacutical and Molecular Therapy (WARMTH): Prof. Ajit Padhy Memorial Oration Award, 2016
• University of Southern California: Best Mentor Award (Faculty-to-Faculty), 2017
• American College of Nuclear Medicine (ACNM): Best Mentor Award, 2018
• Society of Nuclear Medicine and Molecular Imaging (SNMMI): Peter E. Valk MD Memorial Award, 2019
• U.S. Nuclear Regulatory Commission: Advisory Board Member on Medical Uses of Isotopes (Vice Chair 2022-2024, Chair 2024-2027), 2019
   – 2027
• Los Angeles Magazine: Top Doctor (Diagnostic Radiology & Nuclear Medicine), 2020
   – 2024
• Western Regional Society of Nuclear Medicine: Distinguished Service Award, 2020
• University of Southern California: Certificate of Excellence, USC Keck School of Medicine Center for Equity in Medicine and Science, 2021
• American College of Nuclear Medicine (ACNM): Lifetime Achievement Award, 2023
• Association of Nuclear Physicians of India (ANMPI): Prof. RD Lee Oration Award, 2023
• Massachusetts General Hospital, Harvard Medical School: Distinguished Alumnus Award, 2024
• USC Department of Radiology: Outstanding Teacher of the Year, 2023
   – 2024
• U.S. National Academies of Sciences, Engineering, and Medicine (NASEM), Washington, DC: Invited Speaker & Panelist, 2025

• Iowa State University, Ames, IA — BS — 06/1982 — Chemical Engineering
• University of Wisconsin, Madison, WI — MS — 06/1984 — Biomedical Engineering
• University of Michigan, Ann Arbor, MI — MS — 08/1984 — Computer, Information and Control Engineering
• University of Michigan, Ann Arbor, MI — PhD — 08/1988 — Bioengineering
• University of Chicago, Chicago, IL — MD — 06/1993 — Medicine
• University of California, San Francisco, CA — Cert. — 06/1994 — Internal Medicine Clinical Internship
• Stanford University, Stanford, CA — Cert. — 06/1998 — Diagnostic Radiology and Nuclear Medicine Residency
• Harvard Medical School, Boston, MA — Cert. — 06/1999 — Nuclear Oncology/PET Fellowship
• Harvard Medical School, Boston, MA — Cert. — 08/2003 — Clinical Effectiveness Program
• Harvard University, Cambridge, MA — MPH — 08/2005 — Public Health
• University of Southern California (Marshall School of Business), Los Angeles, CA — MBA — 08/2007 — Executive Business Administration
• University of Pennsylvania (Wharton School of Business), Philadelphia, PA — Cert. — 10/2009 — Executive Leadership
• University of Southern California (Gould School of Law), Los Angeles, CA — MSL — 05/2024 — Law Studies

• Novel Dynamic PET/MRI Evlauation of Treatment Response in Brain Tumors
  The Ming Hsieh Institute · Jul 1, 2020 – Aug 31, 2022
• Exploiting the immune microenvironment for radiotargeted destruction of leptomeningeal metastases
  NIH/NCI · R21CA223325 · Sep 1, 2018 – Aug 20, 2020 · Role: Co-Investigator
• Exploiting the pro-metastatic effects of chemotherapy for enhanced detection of peritoneal metastases in ovarian cancer
  The Wright Foundation · Jul 1, 2018 – Jun 30, 2019 · Role: Co-Investigator
• Pilot Human Studies of FMAU PET in Prostate Cancer
  NIH · R21EB017568 · Sep 4, 2015 – Jun 30, 2021 · Role: Principal Investigator
• Disintegrin PET of Prostate Cancer
  Southern California Clinical Translational Science Institute · Sep 1, 2014 – Aug 31, 2016 · Role: Principle Investigator
• [F18]FMAU in Prostate Cancer
  NIH · R21CA142426 · Sep 1, 2009 – Aug 31, 2012 · Role: Principal Investigator
• Biomedical imaging informatics training program
  NIH/NIBIB · T32EB004308 · Sep 1, 2005 – Aug 31, 2010 · Role: Co-Investigator
• FDG PET-CT in Metastatic Prostate Cancer
  NIH · R01CA111613 · Aug 12, 2005 – Dec 31, 2013 · Role: Principal Investigator
• Prediction of cardiomyopathy in type 1 diabetes by 31P MRS
  NIH/NHLBI · R01HL73412 · Aug 15, 2002 – Jul 31, 2007 · Role: Co-Investigator
• Pre-clinical study of choline in human prostate cancer xenografts: preliminary data to support in-vivo imaging with choline PET
  The Wright Foundation · Jul 1, 2002 – Jun 30, 2004 · Role: Principal Investigator
• Role of oxidative metabolism in cancer: validation study with C-14 acetate autoradiography in rats
  Radiological Society of North America · Mar 1, 2002 · Role: Principal Investigator
• Discrimination of inflammation from malignancy with dynamic FDG-PET kinetic analysis
  American Cancer Society · Jul 1, 2000 – Jun 30, 2002 · Role: Principal Investigator

• Nuclear Medicine, PET, Molecular Imaging, Theranostics, Radiopharmaceutical Therapy, Prostate Cancer

• Ulaner, Gary
• Colletti, Patrick
• Conti, Peter
• Gill, Inderbir
• Quinn, David
• Haiman, Christopher